Why the study?
Most clinical practice guidelines for venous thromboembolism prophylaxis after hip and knee arthroplasty and hip fracture reference data that are becoming outdated due to advances in perioperative protocols.
What is the appropriate venous thromboembolism prophylaxis for patients after hip and knee arthroplasty and hip fracture surgery?
What is the appropriate venous thromboembolism prophylaxis for patients after hip and knee arthroplasty and hip fracture surgery?
Current clinical practice guidelines for VTE prophylaxis after orthopedic surgeries may need updating to reflect recent data supporting aspirin for arthroplasty patients.
Answers are grounded in this paper and cite their sources.
May support aspirin for post-arthroplasty VTE prophylaxis but LMWH after hip fracture; leaves open guideline updates absent new RCTs.
Venous thromboembolism is a well-established complication of total hip and knee arthroplasty and hip fracture surgery. Clinical practice guidelines have been proposed to help clinicians provide prophylaxis against this risk. However, most guidelines reference data that are becoming outdated because of new advances in perioperative protocols. Recent data would suggest that aspirin may be appropriate for most patients after total hip and knee replacement and a more potent chemoprophylaxis for higher risk patients. Low-molecular-weight heparin remains the recommended choice after hip fracture surgery, although there is a paucity of recent literature in this patient population. There are randomized trials currently underway in the arthroplasty population that may guide clinicians in the appropriate choice of chemoprophylaxis. These studies should inform updates to the current clinical practice guidelines.
No takes yet. Share an insight, caveat, or question.
Muscatelli et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: